Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion type Assertion NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_head.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion description "[The TTP pathway of TNF-alpha and GM-CSF mRNA degradation is a possible novel target for anti-TNF-alpha therapies for rheumatoid arthritis, and also for other conditions proven to respond to anti-TNF-alpha therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion evidence source_evidence_literature NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion SIO_000772 15535838 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion wasDerivedFrom befree-20150227 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.
- NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_assertion wasGeneratedBy ECO_0000203 NP782154.RAGzz2gvC5T1-syRqN3StsW4Ty-MLF5tu4gTyL10fd3Ew130_provenance.